BIVI BioVie Inc.
Healthcare$1.44-5.26%ClosedMarket Cap: $10.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.73
P/S
0.00
EV/EBITDA
0.07
DCF Value
$12.83
FCF Yield
-178.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-101.1%
ROA
-113.7%
ROIC
-129.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $0.00 | -Infinity% | $-5.4M | $-5.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-6.3M | $-6.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-5.3M | $-5.1M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-3.7M | $-3.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-18.1M | $-17.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.0M | $-2.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-7.3M | $-7.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-4.1M | $-4.2M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-4.8M | $-4.9M | $— | — |
| FY null | $0.00 | NaN% | $-32.2M | $-32.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-7.7M | $-8.1M | $— | — |
| Q2 2024 | $0.00 | NaN% | $-8.8M | $-8.4M | $-2.20 | — |